Info
Significant Ownership

Significant Ownership of Sands Capital Life Sciences Pulse Fund III (DE), L.P.

Signature - Title: /s/ Jonathan Goodman - Jonathan Goodman, General Counsel of the GP of the GP of Sands Capital Life Sciences Pulse Fund III (DE), L.P.
Location: Arlington, VA
Summary: This page shows a list of all the recent SCHEDULE 13D/G filings made by Sands Capital Life Sciences Pulse Fund III (DE), L.P..

Notify me when Sands Capital Life Sciences Pulse Fund III (DE), L.P. files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Sands Capital Life Sciences Pulse Fund III (DE), L.P.

Sym	Company	Class	Ownership	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
	SpyGlass Pharma, Inc.	Common Stock, $0.00001 par value per share	7.8%			2,500,012		SANDS FRANK M.	06 Feb 2026

Schedules 13D/G Reported by Sands Capital Life Sciences Pulse Fund III (DE), L.P.:

Sym	Target	Class	Ownership	Change	Current Shares	Change	Value	Reporting name	Form	Report Period	Filing Date

* An asterisk sign (*) next to the price indicates that the price is likely invalid.